BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31191338)

  • 1. Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.
    Russo R; Marra R; Andolfo I; De Rosa G; Rosato BE; Manna F; Gambale A; Raia M; Unal S; Barella S; Iolascon A
    Front Physiol; 2019; 10():621. PubMed ID: 31191338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease.
    Swickley G; Bloch Y; Malka L; Meiri A; Noy-Lotan S; Yanai A; Tamary H; Motro B
    BMC Mol Cell Biol; 2020 Mar; 21(1):18. PubMed ID: 32293259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex comprising C15ORF41 and Codanin-1: the products of two genes mutated in congenital dyserythropoietic anaemia type I (CDA-I).
    Shroff M; Knebel A; Toth R; Rouse J
    Biochem J; 2020 May; 477(10):1893-1905. PubMed ID: 32239177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and functional insights into CDA-I prevalence and pathogenesis.
    Olijnik AA; Roy NBA; Scott C; Marsh JA; Brown J; Lauschke K; Ask K; Roberts N; Downes DJ; Brolih S; Johnson E; Xella B; Proven M; Hipkiss R; Ryan K; Frisk P; Mäkk J; Stattin EM; Sadasivam N; McIlwaine L; Hill QA; Renella R; Hughes JR; Gibbons RJ; Groth A; McHugh PJ; Higgs DR; Buckle VJ; Babbs C
    J Med Genet; 2021 Mar; 58(3):185-195. PubMed ID: 32518175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.
    Babbs C; Roberts NA; Sanchez-Pulido L; McGowan SJ; Ahmed MR; Brown JM; Sabry MA; ; Bentley DR; McVean GA; Donnelly P; Gileadi O; Ponting CP; Higgs DR; Buckle VJ
    Haematologica; 2013 Sep; 98(9):1383-7. PubMed ID: 23716552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein.
    Russo R; Marra R; Andolfo I; De Rosa G; Rosato BE; Manna F; Gambale A; Raia M; Unal S; Barella S; Iolascon A
    Front Physiol; 2020; 11():940. PubMed ID: 32848870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.
    Noy-Lotan S; Dgany O; Lahmi R; Marcoux N; Krasnov T; Yissachar N; Ginsberg D; Motro B; Resnitzky P; Yaniv I; Kupfer GM; Tamary H
    Haematologica; 2009 May; 94(5):629-37. PubMed ID: 19336738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CDAN1, C15ORF41 and SEC23B mutations in Chinese patients affected by congenital dyserythropoietic anemia.
    Wang Y; Ru Y; Liu G; Dong S; Li Y; Zhu X; Zhang F; Chang YZ; Nie G
    Gene; 2018 Jan; 640():73-78. PubMed ID: 29031773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.
    Murphy ZC; Getman MR; Myers JA; Burgos Villar KN; Leshen E; Kurita R; Nakamura Y; Steiner LA
    Exp Hematol; 2020 Nov; 91():32-38.e6. PubMed ID: 33075436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalities.
    Scott C; Downes DJ; Brown JM; Beagrie R; Olijnik AA; Gosden M; Schwessinger R; Fisher CA; Rose A; Ferguson DJP; Johnson E; Hill QA; Okoli S; Renella R; Ryan K; Brand M; Hughes J; Roy NBA; Higgs DR; Babbs C; Buckle VJ
    Haematologica; 2021 Nov; 106(11):2960-2970. PubMed ID: 33121234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.
    Aydin Koker S; Karapinar TH; Oymak Y; Bianchi P; Fermo E; Gozmen S; Vergin C
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e421-e423. PubMed ID: 29846281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic features of congenital dyserythropoietic anemia (CDA).
    Moreno-Carralero MI; Horta-Herrera S; Morado-Arias M; Ricard-Andrés MP; Lemes-Castellano A; Abio-Calvete M; Cedena-Romero MT; González-Fernández FA; Llorente-González L; Periago-Peralta AM; de-la-Iglesia-Íñigo S; Méndez M; Morán-Jiménez MJ
    Eur J Haematol; 2018 Sep; 101(3):368-378. PubMed ID: 29901818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.
    Dgany O; Avidan N; Delaunay J; Krasnov T; Shalmon L; Shalev H; Eidelitz-Markus T; Kapelushnik J; Cattan D; Pariente A; Tulliez M; Crétien A; Schischmanoff PO; Iolascon A; Fibach E; Koren A; Rössler J; Le Merrer M; Yaniv I; Zaizov R; Ben-Asher E; Olender T; Lancet D; Beckmann JS; Tamary H
    Am J Hum Genet; 2002 Dec; 71(6):1467-74. PubMed ID: 12434312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure modeling to function prediction of Uncharacterized Human Protein C15orf41.
    Ahmed MS; Shahjaman M; Kabir E; Kamruzzaman M
    Bioinformation; 2018; 14(5):206-212. PubMed ID: 30108417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.
    Meznarich JA; Draper L; Christensen RD; Yaish HM; Luem ND; Pysher TJ; Jung G; Nemeth E; Ganz T; Ward DM
    Blood Cells Mol Dis; 2018 Jul; 71():63-66. PubMed ID: 29599085
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Noy-Lotan S; Dgany O; Marcoux N; Atkins A; Kupfer GM; Bosques L; Gottschalk C; Steinberg-Shemer O; Motro B; Tamary H
    Front Physiol; 2021; 12():685242. PubMed ID: 34234691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.
    Kohara H; Utsugisawa T; Sakamoto C; Hirose L; Ogawa Y; Ogura H; Sugawara A; Liao J; Aoki T; Iwasaki T; Asai T; Doisaki S; Okuno Y; Muramatsu H; Abe T; Kurita R; Miyamoto S; Sakuma T; Shiba M; Yamamoto T; Ohga S; Yoshida K; Ogawa S; Ito E; Kojima S; Kanno H; Tani K
    Exp Hematol; 2019 May; 73():25-37.e8. PubMed ID: 30876823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Kulczynska K; Bieker JJ; Siatecka M
    Mol Cell Biol; 2020 Feb; 40(5):. PubMed ID: 31818881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
    Rathe M; Møller MB; Greisen PW; Fisker N
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
    Rössler J; Havers W
    Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.